These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 24810562)

  • 1. Practical experience using galectin-3 in heart failure.
    McCullough PA
    Clin Chem Lab Med; 2014 Oct; 52(10):1425-31. PubMed ID: 24810562
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Utilization of galectin-3 in case management across the spectrum of heart failure.
    McCullough P; de Boer RA; Edelmann F; Lewis CM; Maisel AS
    Rev Cardiovasc Med; 2014; 15(3):197-207. PubMed ID: 25290725
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Galectin-3: a novel blood test for the evaluation and management of patients with heart failure.
    McCullough PA; Olobatoke A; Vanhecke TE
    Rev Cardiovasc Med; 2011; 12(4):200-10. PubMed ID: 22249510
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of galectin-3 and fibrosis markers with long-term cardiovascular outcomes in patients with heart failure, left ventricular dysfunction, and dyssynchrony: insights from the CARE-HF (Cardiac Resynchronization in Heart Failure) trial.
    Lopez-Andrès N; Rossignol P; Iraqi W; Fay R; Nuée J; Ghio S; Cleland JG; Zannad F; Lacolley P
    Eur J Heart Fail; 2012 Jan; 14(1):74-81. PubMed ID: 22089058
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Local expression of myocardial galectin-3 does not correlate with its serum levels in patients undergoing heart transplantation.
    Beiras-Fernandez A; Weis F; Rothkopf J; Kaczmarek I; Ledderose C; Dick A; Keller T; Beiras A; Kreth S
    Ann Transplant; 2013 Nov; 18():643-50. PubMed ID: 24264380
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Galectin-3 testing: validity of a novel automated assay in heart failure patients with reduced ejection fraction.
    Gruson D; Mancini M; Ahn SA; Rousseau MF
    Clin Chim Acta; 2014 Feb; 429():189-93. PubMed ID: 24365381
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Galectin-3 and histological, molecular and biochemical aspects of myocardial fibrosis in heart failure of hypertensive origin.
    López B; González A; Querejeta R; Zubillaga E; Larman M; Díez J
    Eur J Heart Fail; 2015 Apr; 17(4):385-92. PubMed ID: 25684565
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic value of plasma galectin-3 levels in patients with coronary heart disease and chronic heart failure.
    Yu X; Sun Y; Zhao Y; Zhang W; Yang Z; Gao Y; Cai H; Li Y; Wang Q; Bian B; Nie J
    Int Heart J; 2015 May; 56(3):314-8. PubMed ID: 25902879
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic value of galectin-3 in patients with heart failure.
    Bošnjak I; Selthofer-Relatić K; Včev A
    Dis Markers; 2015; 2015():690205. PubMed ID: 25960597
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Galectin-3 in Heart Failure: An Update of the Last 3 Years.
    Gehlken C; Suthahar N; Meijers WC; de Boer RA
    Heart Fail Clin; 2018 Jan; 14(1):75-92. PubMed ID: 29153203
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Galectin-3 in heart failure with preserved ejection fraction.
    de Boer RA; Edelmann F; Cohen-Solal A; Mamas MA; Maisel A; Pieske B
    Eur J Heart Fail; 2013 Oct; 15(10):1095-101. PubMed ID: 23650131
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The relationship between serum galectin-3 and serum markers of cardiac extracellular matrix turnover in heart failure patients.
    Lin YH; Lin LY; Wu YW; Chien KL; Lee CM; Hsu RB; Chao CL; Wang SS; Hsein YC; Liao LC; Ho YL; Chen MF
    Clin Chim Acta; 2009 Nov; 409(1-2):96-9. PubMed ID: 19747906
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multi-center determination of galectin-3 assay performance characteristics: Anatomy of a novel assay for use in heart failure.
    Christenson RH; Duh SH; Wu AH; Smith A; Abel G; deFilippi CR; Wang S; Adourian A; Adiletto C; Gardiner P
    Clin Biochem; 2010 May; 43(7-8):683-90. PubMed ID: 20153309
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The predictive value of plasma biomarkers in discharged heart failure patients: role of galectin-3.
    Leone M; Iacoviello M
    Minerva Cardioangiol; 2016 Apr; 64(2):181-94. PubMed ID: 26426300
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fibrosis marker syndecan-1 and outcome in patients with heart failure with reduced and preserved ejection fraction.
    Tromp J; van der Pol A; Klip IT; de Boer RA; Jaarsma T; van Gilst WH; Voors AA; van Veldhuisen DJ; van der Meer P
    Circ Heart Fail; 2014 May; 7(3):457-62. PubMed ID: 24647119
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Value of pentraxin-3 and galectin-3 in acute coronary syndrome: a short-term prospective cohort study.
    George M; Shanmugam E; Srivatsan V; Vasanth K; Ramraj B; Rajaram M; Jena A; Sridhar A; Chaudhury M; Kaliappan I
    Ther Adv Cardiovasc Dis; 2015 Oct; 9(5):275-84. PubMed ID: 25814534
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Galectin-3 and mineralocorticoid receptor antagonist use in patients with chronic heart failure due to left ventricular systolic dysfunction.
    Gandhi PU; Motiwala SR; Belcher AM; Gaggin HK; Weiner RB; Baggish AL; Fiuzat M; Brunner-La Rocca HP; Januzzi JL
    Am Heart J; 2015 Mar; 169(3):404-411.e3. PubMed ID: 25728731
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Soluble ST2 and Soluble Markers of Fibrosis: Emerging Roles for Prognosis and Guiding Therapy.
    Sharim J; Daniels LB
    Curr Cardiol Rep; 2020 May; 22(6):41. PubMed ID: 32430626
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heart failure with preserved left ventricular ejection fraction in patients with acute myocardial infarction.
    Antonelli L; Katz M; Bacal F; Makdisse MR; Correa AG; Pereira C; Franken M; Fava AN; Serrano Junior CV; Pesaro AE
    Arq Bras Cardiol; 2015 Aug; 105(2):145-50. PubMed ID: 26039659
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Can biomarkers help to diagnose early heart failure with preserved ejection fraction?
    Meluzín J; Tomandl J
    Dis Markers; 2015; 2015():426045. PubMed ID: 25802475
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.